セッション詳細
[P-17-01]Conditions Associated with Deaths in Individuals with Schizophrenia in Psychiatric Units
*Michitaka Funayama1 (1. Ashikaga Red Cross Hospital (Japan))
[P-17-02]Exploring Changes in Recognition and Stigmatization Toward Individuals with Schizophrenia in Singapore from 2014 to 2022
*Ke Cao1, Edimansyah Abdin2, Mythily Subramaniam2 (1. Duke-NUS Medical School (Singapore), 2. Institute of Mental Health (Singapore))
[P-17-03]A study on the treatment of psychosis induced by invocation, Kitousei-Seishinbyo
*Fumiya Miyano1 (1. Department of Psychiatry, Hokkaido University Graduate School of Medicine (Japan))
[P-17-04]PHARMACOTHERAPY OF CATATONIA WITH MODERN ANTIPSYCHOTIC AGENTS: ETHNO-CULTURAL FEATURES OF TREATMENT OF PATIENTS WITH SCHIZOPHRENIA AND COMORBID CHEMICAL ADDICTIONS IN THE NORTHWESTERN AND SIBERIAN FEDERAL DISTRICTS OF RUSSIA.
Georgy Yu. Selivanov1,2,3, Nikolay A. Bokhan1, *Svetlana V. Vladimirova1 (1. Mental Health Research Institute, Tomsk (Russia), 2. Saint Petersburg University of State Fire Service of Emercom of Russia (Russia), 3. Psychiatric Hospital of St. Nicholas, St. Petersburg (Russia))
[P-17-05]Evaluation of ZNF804A (rs1344706) Polymorphism in a Familial Case of Schizophrenia
*Halil ibrahim tas1 (1. Ordu university (Turkey))
[P-17-06]Contemporaneous changes in cytokines and cognitive function during chemotherapy in patients with breast cancer- a prospective follow up study
*Shu-I Wu1, Ching-Hung Chen2 (1. Mackay Memorial Hospital (Taiwan), 2. Chia-Yi Chang Gung Memorial Hospital (Taiwan))